LBD
AMED

Landsberg Bennett & Dubbaneh’s Amedisys AMED Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,346
Closed -$3.05M – 265
2021
Q2 		$3.05M Buy
12,346
+786
+7% +$206K 0.4% 76
2021
Q1 		$3.12M Sell
11,560
-465
-4% -$131K 0.45% 66
2020
Q4 		$3.53M Sell
12,025
-358
-3% -$91.8K 0.54% 54
2020
Q3 		$2.87M Buy
12,383
+8,597
+227% +$1.95M 0.5% 58
2020
Q2 		$748K Buy
+3,786
New +$706K 0.16% 115

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's AMED Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh sold out of Amedisys (AMED) in Q3 2021, closing a stake of 12,346 shares — an estimated $3.05M sold.

Landsberg Bennett & Dubbaneh first reported a position in AMED in Q2 2020 and held it in 5 quarters. The position peaked at $3.53M in Q4 2020. 352 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Landsberg Bennett & Dubbaneh reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Landsberg Bennett & Dubbaneh sold 12,346 Amedisys shares in Q3 2021, an estimated $3.05M.
  • Landsberg Bennett & Dubbaneh first reported a position in Amedisys in Q2 2020 and held it in 5 quarters.
  • Landsberg Bennett & Dubbaneh's Amedisys position peaked at $3.53M in Q4 2020.
  • 352 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.